|
|
||||||||
ORIGINAL RESEARCH |
From the Department of Women and Child Health, Karolinska Hospital, Stockholm, Sweden; and Unit of Electronmicroscopy, Huddinge Hospital, Stockholm, Sweden.
Address reprint requests to: Lena Marions, MD, PhD, Karolinska Hospital, Department of Obstetrics and Gynecology, Stockholm, 171 76, Sweden; E-mail: lena.marions{at}ks.se.
OBJECTIVE: To study the effect of mifepristone and levonorgestrel on ovarian function and endometrial development in doses effective as emergency contraception.
METHODS: Twelve fertile women were treated with either 10 mg of mifepristone as a single dose (n = 6) or two doses of 0.75 mg of levonorgestrel, 12 hours apart (n = 6) before and after ovulation. An endometrial biopsy performed during the implantation period was analyzed for endometrial maturation and expression of markers of endometrial receptivity. The markers tested for were integrin
4 and ß3, cyclooxygenase-1 and -2, progesterone receptors, Dolichos biflorus agglutinin lectin binding, and pinopodes. Urinary excretion of luteinizing hormone, estrone, and pregnanediol were also determined
RESULTS: Treatment with mifepristone and levonorgestrel before ovulation inhibited the luteinizing hormone surge showing no significant differences between the means of luteinizing hormone measurements. When mifepristone was administered in the early luteal phase, downregulation of progesterone receptors was inhibited in five of six women. No significant alteration was found in any of the remaining markers of endometrial receptivity.
CONCLUSION: The mode of action of emergency contraception with mifepristone or levonorgestrel is primarily due to inhibition of ovulation rather than inhibition of implantation.
This article has been cited by other articles:
![]() |
J. W. Campbell III, S. C. Busby, and T. E. Steyer Attitudes and Beliefs About Emergency Contraception Among Patients at Academic Family Medicine Clinics Ann. Fam. Med, January 1, 2008; 6(suppl_1): S23 - S27. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.G.L. Lalitkumar, S. Lalitkumar, C.X. Meng, A. Stavreus-Evers, F. Hambiliki, U. Bentin-Ley, and K. Gemzell-Danielsson Mifepristone, but not levonorgestrel, inhibits human blastocyst attachment to an in vitro endometrial three-dimensional cell culture model Hum. Reprod., November 1, 2007; 22(11): 3031 - 3037. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A.A. do Nascimento, M. Seppala, A. Perdigao, X. Espejo-Arce, M. J. Munuce, L. Hautala, R. Koistinen, L. Andrade, and L. Bahamondes In vivo assessment of the human sperm acrosome reaction and the expression of glycodelin-A in human endometrium after levonorgestrel-emergency contraceptive pill administration Hum. Reprod., August 1, 2007; 22(8): 2190 - 2195. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.R. Massai, M.L. Forcelledo, V. Brache, A.S. Tejada, A.M. Salvatierra, M.V. Reyes, F. Alvarez, A. Faundes, and H.B. Croxatto Does meloxicam increase the incidence of anovulation induced by single administration of levonorgestrel in emergency contraception? A pilot study Hum. Reprod., February 1, 2007; 22(2): 434 - 439. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Karpa Pharmacist Critique Was Ill-Informed Ann. Pharmacother., July 1, 2006; 40(7): 1441 - 1444. [Abstract] [Full Text] [PDF] |
||||
![]() |
Committee on Adolescence Emergency Contraception Pediatrics, October 1, 2005; 116(4): 1026 - 1035. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Leminen, T. Raivio, S. Ranta, J. Oehler, H. von Hertzen, O. A Janne, and O. Heikinheimo Late follicular phase administration of mifepristone suppresses circulating leptin and FSH - mechanism(s) of action in emergency contraception? Eur. J. Endocrinol., March 1, 2005; 152(3): 411 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Gemzell-Danielsson and L. Marions Mechanisms of action of mifepristone and levonorgestrel when used for emergency contraception Hum. Reprod. Update, July 1, 2004; 10(4): 341 - 348. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |